ALGN
ALIGN TECHNOLOGY INC
NASDAQ · Healthcare · Medical - Devices · US
$166.36
+9.75%Next report
Analyst consensus
- Next report date
- Feb 3, 2027
- EPS estimate
- $3.06
- Revenue estimate
- $1.0B
Latest reported
- Last report date
- Oct 28, 2026
- EPS actual
- $2.80
- EPS estimate
- $2.78
- Revenue actual
- $1.0B
- Revenue estimate
- $1.0B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 3
- Avg surprise (4Q)
- +6.4%
- Revenue beats (12Q)
- 4
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $184
- PT range
- $155 – $215
- Analysts
- 7
4 Buy3 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 28, 2026 | $2.78 | $2.80 | Beat 0.86% | $1.0B |
| Jul 29, 2026 | $2.63 | $2.64 | Beat 0.53% | $1.1B |
| Apr 29, 2026 | $2.26 | $2.58 | Beat 14.16% | $1.0B |
| Feb 4, 2026 | $2.99 | $3.29 | Beat 10.03% | $1.0B |
| Oct 29, 2025 | $2.40 | $2.61 | Beat 8.75% | $995.7M |
| Jul 30, 2025 | $2.57 | $2.49 | Miss -3.11% | $1.0B |
| Apr 30, 2025 | $1.99 | $2.13 | Beat 7.04% | $979.3M |
| Feb 5, 2025 | $2.43 | $2.44 | Beat 0.41% | $995.2M |
| Oct 23, 2024 | $2.31 | $2.35 | Beat 1.73% | $977.9M |
| Jul 24, 2024 | $2.34 | $2.41 | Beat 2.99% | $1.0B |
| Jan 31, 2024 | $2.18 | $2.42 | Beat 11.01% | $956.7M |
| Oct 25, 2023 | $2.26 | $2.14 | Miss -5.31% | $960.2M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 3, 2027